About the MLSE

The MLSE is a new short cognitive test, with a scoring system that is easy to learn and apply. It is accurate for classifying PPA syndromes, and has potential to screen and monitor language deficits that occur in other focal and neurodegenerative brain disorders associated with language impairment. increasing importance of language assessment in clinical research, the MLSE’s linguistic assessment tool enables the essential profiling of language deficits in a wide clinical community. colorful-brain-map-vector-clipart

Participating Centres

  • St George’s, University of London (Lead Centre)

 

  • University of Cambridge

 

  • University of Manchester

 

  • Istituto Universitario di Studi Superiori di Pavia

Project Team

Chief Investigator:
Professor Peter Garrard
(St George’s, University of London)

 

 

Research Team:

Dr Nikil Patel (St George’s, University of London)

Dr Katie Peterson (MRC Cognition and Brain Sciences Unit, University of Cambridge)

Dr Eleonora Catricalà (Istituto Universitario di Studi Superiori, Pavia, Italy)

Dr Leticia Vivas (Investigadora de CONICET)

Ms Irina Giosanu (St George’s, University of London)

Ms Ruth Ingram (University of Manchester)

Dr Ajay Halai (University of Cambridge)

Mr Ian Storey (St George’s, University of London)

Ms Angela Ramcharan (St George’s, University of London)

Principal Investigators:

Professor James Rowe (MRC Cognition and Brain Sciences Unit, University of Cambridge)

Professor Karalyn Paterson (MRC Cognition and Brain Sciences Unit, University of Cambridge)

Professor Matt Lambon Ralph (MRC Cognition and Brain Sciences Unit, University of Cambridge)

Professor Stefano Cappa (Istituto Universitario di Studi Superiori, Pavia, Italy)

Dr Thomas Barrick (St George’s, University of London)

Project Collaborators:

– Professor Argye Hillis (Johns Hopkins University)

– Professor Cristiano Chesi (Istituto Universitario di Studi Superiori, Pavia, Italy)

– Professor Roger Barker (University of Cambridge)

– Professor Fernando Cuetos (University of Oviedo)

– Dr Jordi Matias-Guiu (Hospital Clinico Universitario San Carlos: Madrid, Madrid, ES)

– Dr Alex Pantelyat (Johns Hopkins University)

-Dr Arshia Seddigh (Tehran University of Medical Sciences)